Tuberculosis resistance patterns at a prison in Lima, Peru Source: Eur Respir J 2003; 22: Suppl. 45, 555s Year: 2003
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Tuberculosis prophylaxis in HIV patients in Tomsk penitentiary system, Russia Source: Annual Congress 2008 - COPD and miscellaneous Year: 2008
The tale of two hospitals: Urban and suburban patients with tuberculosis and their outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Predisposing factors of multi drug resistant tuberculosis (MDR-TB) in Sardjito Hospital, Yogyakarta, Indonesia in 2009-2012 Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Risk factors for tuberculosis relapse in Polish patients Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Tuberculosis in eastern Turkey and the associated risk factors Source: Eur Respir J 2005; 26: Suppl. 49, 192s Year: 2005
Trend in TB control in Republic of Moldova: High MDRTB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Risk factors for HIV and multiple drug resistant tuberculosis in civilian and penitentiary sectors in Samara, Russia Source: Eur Respir J 2003; 22: Suppl. 45, 345s Year: 2003
Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Latent TB in healthcare workers from high prevalence countries at city hospital Sunderland foundation trust (CHSFT); epidemiology and management Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
Tuberculosis costs in Spain and related factors Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Evaluation of risk factors for mortality among ARDS patients in Hyderabad, south India Source: Eur Respir J 2007; 30: Suppl. 51, 581s Year: 2007
Increased incidence of TB disease within the health-care workers in an intermediate TB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Co-morbid conditions associated with tuberculosis (TB): Results from a 1-day, point-prevalence study in 204,912 physician diagnosed patients from 880 cities and towns in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Risk factors for the default from DOTS - experience of the Iasi County, Romania Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005